Interactive Effects of HDL Cholesterol and hs-CRP in Relation to Cardiometabolic Risk Clustering Among Middle-Aged

Heeyoung Hwang1, Gitak Bae2, Kyeongmin Jang3

  • 1Myongji St. Mary's Hospital, Seoul 07417, Republic of Korea.

Insights

Systemic inflammation modifies the link between high-density lipoprotein cholesterol (HDL-C) and cardiometabolic risk clustering (CMRC) in middle-aged adults. This suggests inflammatory status impacts how HDL-C levels relate to developing multiple risk factors.

Area of Science:

  • Cardiovascular Disease Epidemiology
  • Metabolic Syndrome Research
  • Biomarker Interaction Studies

Background:

  • Cardiometabolic risk factors often cluster, significantly elevating cardiovascular disease (CVD) risk.
  • High-density lipoprotein cholesterol (HDL-C) and systemic inflammation (hs-CRP) are independently linked to cardiometabolic risk.
  • The modifying effect of systemic inflammation on the HDL-C-cardiometabolic risk clustering association is not well understood.

Purpose of the Study:

  • To investigate the independent associations of HDL-C and hs-CRP with cardiometabolic risk clustering (CMRC).
  • To evaluate the multiplicative interaction between HDL-C and natural log-transformed hs-CRP concerning CMRC.
  • To analyze these relationships in middle-aged Korean adults.

Main Methods:

  • Cross-sectional study utilizing data from 2283 adults aged 40-64 from the 2024 Korea National Health and Nutrition Examination Survey.
  • CMRC defined as the presence of two or more cardiometabolic risk factors.
  • Complex sample logistic regression analyzed HDL-C, ln hs-CRP, and their interaction term (HDL-C × ln hs-CRP).

Main Results:

  • The prevalence of CMRC was 46.4%.
  • HDL-C showed an inverse association with CMRC (OR=0.946, p<0.001), while ln hs-CRP demonstrated a positive association (OR=1.224, p=0.030).
  • A significant interaction between HDL-C and ln hs-CRP was observed (OR=1.005, p=0.008), indicating potential effect modification.

Conclusions:

  • Both HDL-C and ln hs-CRP are independently associated with CMRC in middle-aged adults.
  • The significant interaction term suggests that systemic inflammation may modify the association between HDL-C and CMRC.
  • Findings require cautious interpretation; no causal or mechanistic relationship is established.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...